Associations between negative symptoms, service use patterns, and costs in patients with Schizophrenia in five European countries

Clinical Neuropsychiatry

Volumn 5, Issue 4, 2008, Pages 195-205

  Knapp, Martin ^a,b   McCrone, Paul ^b   Leeuwenkamp, Oscar ^c  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cost; Negative symptoms; Schizophrenia; Service use pattern

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; NEGATIVE SYNDROME; SCHIZOPHRENIA;

EID: 57749191016     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. American Psychiatric Association (APA) (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. American Psychiatric Association, Washington, DC.
2. Becker T, Knapp M, Knudsen HC, Schene A, Tansella M, Thornicroft G, Vazquez-Barquero, JL (1999). The EPSILON study of schizophrenia in five European countries. Design and methodology for standardising outcome measures and comparing patterns of care and service costs. British Journal of Psychiatry175, 514-521.
3. Becker T, Knapp M, Knudsen HC, Schene AH, Tansella M, Thornicroft G, Vazquez-Barquero JL (2000). Aims, outcome measures, study sites and patient sample. EPSILON Study 1. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. British Journal of Psychiatry 177, Suppl 39, S1-7.
4. Bressan RA, Costa DC, Jones HM, Ell PJ, Pilowsky LS (2002). Typical antipsychotic drugs - D(2) receptor occupancy and depressive symptoms in schizophrenia. Schizophrenia Research 56, 31-6.
5. Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B (2000). Client Socio-Demographic and Service Receipt Inventory-European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. British Journal of Psychiatry 177, Suppl 39, S28-33.
6. Davies LM, Drummond MF (1994). Economics and schizophrenia: the real cost. British Journal of Psychiatry 165, Suppl 25, S18-21.
7. Dixon L, Lyles A, Smith C, Hoch JS, Fahey M, Postrado L, Lucksted A, Lehman A (2001). Use and costs of ambulatory care services among Medicare enrollees with schizophrenia. Psychiatric Services 52, 786-792.
8. Dunn G, Mirandola M, Amaddeo F, Tansella M (2003). Describing, explaining or predicting mental health care costs: a guide to regression models. Methodological review. British Journal of Psychiatry 183, 398-404.
9. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766-771.
10. Evers SM, Ament AJ (1995). Costs of schizophrenia in The Netherlands. Schizophrenia Bulletin 21, 141-153.
11. Horan WP, Kern RS, Shokat-Fadai K, Sergi MJ, Wynn JK, Green MF (2008). Social cognitive skills training in schizophrenia: An initial efficacy study of stabilized outpatients. Schizophrenia Research Oct 16 (Epub ahead of print).
12. Hu TW (2006). Perspectives: an international review of the national cost estimates of mental illness, 1990-2003.J of Mental Health Policy and Economics 9, 3-13.
13. Knapp M, Chisholm D, Leese M, Amaddeo F, Tansella M, Schene A, Thornicroft G, Vazquez-Barquero JL, Knudsen HC, Becker T (2002). Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Acta Psychiatrica Scandinavica 105, 42-54.
14. Knapp M, Mangalore R, Simon J (2004). The global costs of schizophrenia. Schizophrenia Bulletin 30, 279-293.
15. Lukoff D, Neuchterlein KH, Ventura J (1986). Manual for the expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin 12, 594-602.
16. Mangalore R, Knapp M (2007). Cost of schizophrenia in England. Journal of Mental Health Policy and Economics 10, 23-41.
17. McGurk SR, Mueser KT, Walling D, Harvey PD, Meltzer HY (2004). Cognitive functioning predicts outpatient service utilization in schizophrenia. Mental Health Services Research 6, 185-188.
18. Mohr PE, Cheng CM, Claxton K, Conley RR, Feldman JJ, Hargreaves WA, Lehman AF, Lenert LA, Mahmoud R, Marder SR, Neumann PJ (2004). The heterogeneity of schizophrenia in disease states. Schizophrenia Research 71. 83-95.
19. Oliva-Moreno J, Lopez-Bastida J, Osuna-Guerrero R, Montejo-Gonzalez AL, Duque-Gonzale, B (2006). The costs of schizophrenia in Spain. European Journal of Health Economics 7, 182-188.
20. Oliver JP, Huxley PJ, Priebe S, Kaiser W (1997). Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatric Epidemiology 32, 76-83.
21. Phelan M, Slade M, Thornicroft G, Dunn G, Holloway F, Wykes T, Strathdee G, Loftus L, McCrone P, Hayward P (1995). The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. British Journal of Psychiatry 167, 589-595.
22. Rice DP, Miller LS (1998). Health economics and cost implications of anxiety and other mental disorders in the United States. British Journal of Psychiatry 173, Suppl 34, S4-9.
23. Ruggeri M, Dall'Agnola R (1993). The development and use of the Verona Expectations for Care Scale (VECS) and the Verona Service Satisfaction Scale (VSSS) for measuring expectations and satisfaction with community-based psychiatric services in patients, relatives and professionals. Psychological Medicine 23, 511-523.
24. Ruggeri M, Koeter M, Schene A, Bonetto C, Vazquez-Barquero JL, Becker T, Knapp M, Knudsen HC, Tansella M, Thornicroft G (2005). Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries. Schizophrenia Research 75, 107-117.
25. Steinert T, Krueger M, Gebhardt RP (1999). Costs of treatment and outcome measures in schizophrenia. European Journal of Psychiatry 13, 209-214.